Evidence map›Paper›PMID 25531759›Full record

ArticlePloS one2014

Renal function in hepatosplenic schistosomiasis--an assessment of renal tubular disorders.

Daniella Bezerra Duarte, Lucas Alexandre Vanderlei, Raianne Kívia de Azevêdo Bispo, Maria Eliete Pinheiro, Geraldo Bezerra da Silva, Alice Maria Costa Martins, Gdayllon Cavalcante Meneses, Elizabeth De Francesco Daher

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Kidney complications of parasitic diseases.Nature reviews. Nephrology · 2022
    Review
  4. Article
  5. Article
  6. Kidney biomarkers in tropical infections: an update.Pathogens and global health · 2020
    Review
  7. Novel kidney injury biomarkers in tropical infections: a review of the literature.Revista do Instituto de Medicina Tropical de Sao Paulo · 2020
    Review
  8. Schistosoma mansoni PCRClinical and experimental immunology · 2019
    Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Daniella Bezerra DuarteDepartment of Internal Medicine, School of Medicine, Federal University of Alagoas, Maceió, AL, Brazil; Department of Internal Medicine, Post-Graduation Program in Medical Sciences, School of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil.
Lucas Alexandre VanderleiDepartment of Internal Medicine, School of Medicine, Federal University of Alagoas, Maceió, AL, Brazil.
Raianne Kívia de Azevêdo BispoDepartment of Internal Medicine, School of Medicine, Federal University of Alagoas, Maceió, AL, Brazil.
Maria Eliete PinheiroDepartment of Internal Medicine, School of Medicine, Federal University of Alagoas, Maceió, AL, Brazil.
Geraldo Bezerra da SilvaSchool of Medicine, Post-Graduation Program in Collective Health, Health Sciences Center, University of Fortaleza, Fortaleza, CE, Brazil.
Alice Maria Costa MartinsDepartment of Pharmacy and Clinical Analysis, Federal University of Ceará, Fortaleza, CE, Brazil.
Gdayllon Cavalcante MenesesDepartment of Pharmacy and Clinical Analysis, Federal University of Ceará, Fortaleza, CE, Brazil.
Elizabeth De Francesco DaherDepartment of Internal Medicine, Post-Graduation Program in Medical Sciences, School of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil.
Universidade Federal do Ceará · BRUniversidade Federal de Alagoas · BRUniversidade de Fortaleza · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal involvement in Schistosoma mansoni infection is not well studied. The aim of this study is to investigate the occurrence of renal abnormalities in patients with hepatosplenic schistosomiasis (HSS), especially renal tubular disorders.

methodsThis is a cross-sectional study with 20 consecutive patients with HSS followed in a medical center in Maceió, Alagoas, Brazil. Urinary acidification and concentration tests were performed using calcium chloride (CaCl2) after a 12-h period of water and food deprivation. The biomarker monocyte chemoattractant protein 1 (MCP-1) was quantified in urine. Fractional excretion of sodium (FENa+), transtubular potassium gradient (TTKG) and solute-free water reabsorption (TcH2O) were calculated. The HSS group was compared to a group of 17 healthy volunteers.

resultsPatients' mean age and gender were similar to controls. Urinary acidification deficit was found in 45% of HSS patients. Urinary osmolality was significantly lower in HSS patients (588 ± 112 vs. 764 ± 165 mOsm/kg, p = 0,001) after a 12-h period of water deprivation. TcH2O was lower in HSS patients (0.72 ± 0.5 vs. 1.1 ± 0.3, p = 0.04). Urinary concentration deficit was found in 85% of HSS patients. The values of MCP-1 were higher in HSS group than in control group (122 ± 134 vs. 40 ± 28 pg/mg-Cr, p = 0.01) and positively correlated with the values of microalbuminuria and proteinuria.

conclusionsHSS is associated with important kidney dysfunction. The main abnormalities found were urinary concentrating ability and incomplete distal acidification defect, demonstrating the occurrence of tubular dysfunction. There was also an increase in urinary MCP-1, which appears to be a more sensitive marker of renal damage than urinary albumin excretion rate.

Indexed as

AdultAlbuminuriaChemokine CCL2Cross-Sectional StudiesFemaleGlomerular Filtration RateHumansHydrogen-Ion ConcentrationKidneyKidney DiseasesMaleMiddle AgedNeglected DiseasesOsmolar ConcentrationProteinuriaSchistosomiasisChemokine CCL2

Identifiers

PMID25531759
PMCPMC4274079
OpenAlexW1990412386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.